TriSalus Life Sciences, Inc.

TLSI

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001826667

SEC filings (opens in a new tab)

No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.

Other share classesTLSIW

Q1 2026 vs. Q4 2025

How the institutions holding TriSalus Life Sciences, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of TLSI: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	64	2	84	+22
Shares	11.4M	1.68M	20.9M	+11.1M (+114.3%)
Value	$79.6M	$11.7M	$83.4M	+$15.5M (+22.8%)

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to TLSI in Q1 2026
Institution	Shares	Value	% of portfolio
First Light Asset Management, LLC	5,066,827	$20.3M	1.82%
Wasatch Advisors Inc	1,437,960	$5.75M	0.04%
Vanguard Capital Management LLC	1,347,036	$5.39M	0.00%
Cerity Partners LLC	787,272	$3.15M	0.00%
Thompson Siegel & Walmsley LLC	583,574	$2.33M	0.04%
Kennedy Capital Management, Inc.	485,242	$1.94M	0.04%
Perkins Capital Management Inc	230,101	$920.4K	0.86%
Vanguard Fiduciary Trust Co	218,352	$873.4K	0.00%
Royce & Associates LP	200,060	$800.2K	0.01%
Apis Capital Advisors, LLC	180,000	$720.0K	0.11%
Vanguard Portfolio Management LLC	164,858	$659.4K	0.00%
CI Private Wealth, LLC	91,000	$364.0K	0.00%
SEI Investments Co	68,870	$275.5K	0.00%
Intrust Bank NA	66,000	$264.0K	0.02%
Formula Growth Ltd	50,000	$200.0K	0.09%
Renaissance Technologies LLC	30,900	$123.6K	0.00%
Ghisallo Capital Management LLC	25,000	$100.0K	0.00%
Captrust Financial Advisors	21,965	$87.9K	0.00%
XTX Topco Ltd	19,014	$76.1K	0.00%
Vanguard Global Advisers, LLC	15,268	$61.1K	0.00%
Susquehanna International Group, LLP	12,994	$52.0K	0.00%
JDM Financial Group LLC	530	$2.12K	0.00%
Wolverine Asset Management LLC	346	$1.38K	0.00%
MAI Capital Management	15	$60	0.00%
Root Financial Partners, LLC	12	$48	0.00%
Advisory Services Network, LLC	7	$28	0.00%
EverSource Wealth Advisors, LLC	5	$20	0.00%
Caitong International Asset Management Co., Ltd	5	$20	0.00%
Rothschild Investment LLC	2	$8	0.00%
Sunbelt Securities, Inc.	2	$8	0.00%
Allworth Financial LP	1	$4	0.00%
Farther Finance Advisors, LLC	1	$4	0.00%

Sold out (10)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of TLSI in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Wealthcare Advisory Partners LLC	643,740	$4.49M
Alyeska Investment Group, L.P.	407,500	$2.84M
Squarepoint Ops LLC	44,371	$309.7K
Millennium Management LLC	35,679	$249.0K
Laird Norton Trust Company, LLC	34,950	$244.0K
Connective Capital Management, LLC	32,796	$228.9K
MetLife Investment Management	18,135	$126.6K
Abel Hall, LLC	10,500	$73.3K
Royal Bank of Canada	1,194	$8.00K
Amalgamated Bank	956	$7.00K

Not filed for Q1 2026 yet (2)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TLSI in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	1,530,707	$10.7M
Kotler Kevin	145,200	$1.01M